C07D 231/04
Having no double bonds between ring members or between ring members and
Official title: having no double bonds between ring members or between ring members and non-ring members
C07D231/04 (Having no double bonds between ring members or between ring members and) appears on 69 US grants and 62 published applications in this corpus.
Search patents in C07D- Granted patents
- 69
- Published applications
- 62
- Assignees
- 64
- Inventors
- 242
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 1 | 1 |
| 2004 | 1 | 4 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 3 | 1 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 3 | 1 |
| 2011 | 2 | 3 |
| 2012 | 2 | 3 |
| 2013 | 1 | 1 |
| 2014 | 3 | 6 |
| 2015 | 1 | 1 |
| 2016 | 2 | 3 |
| 2017 | 2 | 3 |
| 2018 | 2 | 3 |
| 2019 | 1 | 3 |
| 2020 | 3 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 5 |
| 2023 | 2 | 3 |
| 2024 | 2 | 3 |
| 2025 | 1 | 1 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors for programmed cell necrosis and preparation method therefor and use thereof23 Jun 2026US 12,662,473 B2Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Dimers for use in synthesis of peptidomimetics12 May 2026US 12,624,002 B2The Feinstein Institutes for Medical Research
- Antibody-ALK5 inhibitor conjugates and their uses18 Nov 2025US 12,473,377 B2Synthis Therapeutics, Inc.
- Decarboxylase inhibitors for treating Parkinson's disease10 Dec 2024US 12,162,902 B2Sail Biomedicines
- ALK5 inhibitors and their uses21 May 2024US 11,987,558 B1Synthis Therapeutics, Inc.
- Resist composition, resist pattern formation method, compound, and acid generator6 Aug 2026US 2026/0227692 A1Tokyo Ohka Kogyo.Co., Ltd.
- Resist composition, method for forming resist pattern, compound, and acid diffusion control agent30 Jul 2026US 2026/0219568 A1Tokyo Ohka Kogyo.Co., Ltd.
- Alkylphenyl Substituted Compounds, Compositions and Methods of Use14 May 2026US 2026/0132119 A1Deep Apple Therapeutics, Inc.
- Antibody-alk5 inhibitor conjugates and their uses19 Feb 2026US 2026/0049159 A1Synthis Therapeutics, Inc.
- Sarm1 modulators, preparations, and uses thereof16 Oct 2025US 2025/0320184 A1Sironax Ltd.
Most cited
By later US patents
- Pyridazo[1,2-a][1,2]diazepines89US 4,512,924 AHoffmann-La Roche Inc. · 1985
- 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method59US 6,573,287 B2Bristo-Myers Squibb Company · 2003
- Inhibitors of glutaminyl cyclase53US 7,371,871 B2Probiodrug AG · 2008
- Alpha-amino acid sulphonyl compounds52US 6,716,843 B2Les Laboratoires Servier · 2004
- Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators31US 8,748,412 B2Argusina Bioscience Inc. · 2014